Abstract Context: The link between Hashimoto's thyroiditis (HT) and papillary thyroid cancer
(PTC) has long been a topic of controversy. There are conflicting reports; some suggest that …

Abstract Context: Thyroglobulin autoantibodies (TgAb) are primarily measured in serum in
conjunction with thyroglobulin (Tg)—the primary tumor marker used to monitor patients with …

Background: Thyroid nodules are a common clinical problem, and differentiated thyroid
cancer is becoming increasingly prevalent. Since the publication of the American Thyroid …

Objective No consensus exists on the association between papillary thyroid carcinoma
(PTC) and Hashimoto's thyroiditis (HT). To resolve this controversy, this study aimed to …

Context: TSH is a known thyroid growth factor, but the pathogenic role of TSH in thyroid
oncogenesis is unclear. Objective: The aim was to examine the relationship between …

Background The incidence of thyroid cancer (TC) is increasing although explanatory causes
are lacking. A link between cancer and inflammation is well documented but unclear for …

Context: TSH is the main factor involved in the control of proliferation of thyrocytes. Recently,
a strong relationship between serum TSH and risk of thyroid malignancy has been reported …

BACKGROUND: Hashimoto's thyroiditis is the most common cause of hypothyroidism and is
characterized by gradual autoimmune mediated thyroid failure with occasional goiter …

Thyroglobulin autoantibodies (TgAb) are detected at diagnosis or during treatment in
approximately 25% of patients with differentiated thyroid cancer (DTC). When present, TgAb …

Background: Even though the presence of antithyroglobulin antibodies (TgAbs) represents a
significant problem in the follow-up of patients with differentiated thyroid cancer (DTC), the …